Follow @stockring   Enter Stock:                    Download StockRing Free  Buy-Sell-Hold iPhone App for 1,200 stocks in Energy Healthcare Finance Services & Tech DOW 30+ ENERGY HEALTH FINANCE SERVICES TECH BUY  DOW 30+: WSM  WAB  VZ  VFC  UTX     ENERGY: WES  TCP  SXL  RGP  RES     HEALTH: WX  UTMD  THOR  STJ  SNY        FINANCE: VR  TFSL  PVD  PRA  OB     SERVICES: WIN  ULTA  TKC  TDS  SYY     TECH: WDC  SWIR  RENN  ONNN  NTAP  SELL  DOW 30+: WPZ  WERN  VALE  TCK  SQM     ENERGY: YZC  YPF  XOM  XEC  XCO     HEALTH: ZTS  ZMH  XRAY  XOMA  WST        FINANCE: ZION  Y  XLI  XLB  WTM     SERVICES: WYNN  WYN  WTW  WMT  WM     TECH: YNDX  XRX  XLNX  WIT  WCC    DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX    Our FREE iPhone App gives Buy-Sell-Hold ratings for 1,200 stocks!  1. Dow 30+ - 200 Stocks   on  TODAY :   Buy   44% or 89    Hold   44% or 86    Sell   12% or 25  2. Energy - 200 Stocks   on 6/13/2013:   Buy   8% or 16    Hold   30% or 61    Sell   62% or 123  3. Health - 200 Stocks   on 6/13/2013:   Buy   20% or 40    Hold   46% or 91    Sell   34% or 69  4. Finance - 200 Stocks   on 6/13/2013:   Buy   8% or 15    Hold   32% or 66    Sell   60% or 119  5. Services - 200 Stocks   on 6/13/2013:   Buy   4% or 7    Hold   30% or 62    Sell   66% or 131  6. Tech - 200 Stocks   on 6/13/2013:   Buy   6% or 11    Hold   35% or 71    Sell   59% or 118     TOTAL RATING:   Buy   15% or 178    Hold   36% or 437    Sell   49% or 585    DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX    Our FREE iPhone App with Buy-Sell-Hold ratings for 1,200 stocks:   iPhone App Buy-Sell-Hold Ratings for 5-5-2013                                                              Enter Stock:                  6/18/2013  Tuesday, June 18, 2013 (Irvine, California) Today StockRing.com Recommendation is to "SELL"for Cubist Pharmaceut (NASDAQ:CBST) Stock. CBST stock opening price was $50.02 per share. Current price of NASDAQ:CBST Stock is $51.13 per share and it is $+1.16, (+2.32%) today and it was trading in the daily range of $49.82 - 51.13 per share. Current Bid Price for (NASDAQ:CBST) stock is $50.75 and the Ask Price is $52.39. In the last 52 weeks CBST stock was trading in the range of $36.73 - 49.86. 50-Day Moving Average for (NASDAQ:CBST) stock is $46.57 and 200-Day Moving Average is $43.84. On average analysts predict that One Year Target Estimated price for (NASDAQ:CBST) stock is $56.07. Cubist Pharmaceut (NASDAQ:CBST) is rated as a sell on 6/13/2013 7:04:57 AM. Cubist Pharmaceut (NASDAQ:CBST) Market capitalization is $3.334B. (NASDAQ:CBST) stock average daily volume is 739,858 shares per day. However, on last trading session of Jun 18, 2012 CBST stock traded 762,394 shares. Also The Number of days it would take short sellers on average to repurchase all the borrowed shares or Short Ratio for (NASDAQ:CBST) stock is 8.00. On previous trading session CBST Stock closed at $49.97 per share. Last year Cubist Pharmaceut (NASDAQ:CBST) before taxes (EBITDA) (ttm) earned $254.4M on total revenue of $944.6M. Earnings Per Share - EPS (ttm) for CBST stock is 1.8. Also, (NASDAQ:CBST) Stock Price Per Earnings ratio - P/E is 27.82. Thus, (NASDAQ:CBST) Stock Price/Sales (ttm) ratio is 3.45 and Price/Book (mrq) ratio is 3.21. (NASDAQ:CBST) Stock does NOT PAY any dividend. So at this time (NASDAQ:CBST) Stock maintains Trailing Annual Dividend Rate at 0.00 . StockRing Recommendations for Cubist Pharmaceut (NASDAQ:CBST) Stock are updated daily here http://StockRing.com/sr/Buy-Sell-Hold-Stock-Analysis-Ratings.asp?StockName=CBST At this time StockRing recommends to buy LONG positions on many stocks from Dow 30+ stocks that currently have a BUY or SUPER BUY rating. If you decide to take a SHORT position and actually sell some stocks sjort right now - please check the section of Dow 30+ stocks that have a SELL or SUPER SELL rating. If you would like to receive Buy-Sell-Hold ratings for stocks from Energy, Healthcare, Finance, Services & Hi-Tech sectors on your iPhone, then please download Buy-Sell-Hold iPhone App here: Free Limited or $10 Full Version  Buy-Sell-Hold iPhone App for 1,200 stocks in Energy, Healthcare, Finance, Services and Tech DOW 30+ ENERGY HEALTH FINANCE SERVICES TECH     Enter Stock:                    DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX    NASDAQ:CBST Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info 6/18/2013 1 Year Stock market price chart for Cubist Pharmaceut (NASDAQ:CBST) Stock on Tuesday, June 18, 2013    1 Year CBST 1 Year Dow Jones 1 Year Nasdaq 1 Year S&P 500 6/18/2013 5 days Stock market price chart for Cubist Pharmaceut (NASDAQ:CBST) Stock on Tuesday, June 18, 2013    5 Days CBST 5 Days Dow Jones 5 Days Nasdaq 5 Days S&P 500    EUROs for $1 DOLLAR: 30 days       NASDAQ:CBST Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info   DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX    6/18/2013 Stock market price quote data for Cubist Pharmaceut (NASDAQ:CBST) Stock on Tuesday, June 18, 2013

Last Trade: 51.13 Trade Time: Jun 18 Change: +1.16, (+2.32%) Prev Close: 49.97 Open: 50.02 Bid: 50.75 Ask: 52.39 1y Target Est: $56.07 50-Day Moving Average: 46.57 200-Day Moving Average: 43.84 Short Ratio: 8.00 Trailing Annual Dividend Rate: 0.00

Day's Range: 49.82 - 51.13 52wk Range: 36.73 - 49.86 Volume: 762,394 Avg Vol: 739,858 Market Cap: 3.334B P/E (ttm): 27.82 EPS (ttm): 1.8 Div & Yield: 0.00 (N/A%) Revenue (ttm): 944.6M Earnings before Tax (EBITDA) (ttm): 254.4M Price/Sales (ttm): 3.45 Price/Book (mrq): 3.21

DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX

DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX

 

DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX

CUBIST PHARMACEUTICALS INC : Cubist Names Dr. Lorianne Masuoka Chief ... 4-traders (press release) - Jun 13, 2013 Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist Pharmaceuticals, Inc., Lexington Boston.com - Jun 14, 2013 Sending your article. Lorianne Masuoka is now chief medical officer and senior vice president of clinical development and medical affairs at Cubist Pharmaceuticals, Inc., a bio-pharmaceutical company in Lexington. Comments (); E-mail story; Print story ... Cubist Names Dr. Lorianne Masuoka Chief Medical Officer - DailyFinance Here is What Hedge Funds Think About Cubist Pharmaceuticals Inc (CBST) Insider Monkey (blog) - May 31, 2013 Cubist Pharmaceuticals Inc (NASDAQ:CBST) was in 22 hedge funds' portfolio at the end of March. CBST investors should pay attention to an increase in hedge fund interest of late. Cubist Pharmaceuticals shares leap late after ruling on patent cases MarketWatch (blog) - May 20, 2013 By Russ Britt. A flurry of late trading drove up shares of Cubist Pharmaceuticals Inc. Monday on news the company prevailed in a hearing on a patent infringement case involving a key drug in its product line. Cubist Pharmaceuticals Inc. (CBST) Leaped To A New High In Late Trade - RTT News AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), NPS Pharmaceuticals, Inc ... - SBWire (press release) CUBIST PHARMACEUTICALS INC : Cubist Achieves Top Biotech Ranking in ... 4-traders (press release) - May 19, 2013 For the fifth consecutive year, Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) has been named to the Globe 100 annual list, the Boston Globe's annual ranking of the 100 top-performing public companies headquartered in Massachusetts. Tech firms are the guiding stars for the Mass. economy - Boston Globe CUBIST PHARMACEUTICALS INC : Cubist to Present at Jefferies 2013 Global ... 4-traders (press release) - May 23, 2013 Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Mike Bonney, Cubist's CEO, will present at Jefferies 2013 Global Healthcare Conference on Monday, June 3, to discuss the company's business activities, financial outlook, and current ... Cubist Pharmaceuticals Stock Rating Lowered by Janney Montgomery Scott ... Watch List News (press release) - May 28, 2013 Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. Seven Most Active Stocks Watch List: Pinnacle Entertainment, Rexnord, Terex ... Equity Observer - 14 hours ago With a recent loss of -0.40%, to $49.97, the share price of Cubist Pharmaceuticals Inc (NASDAQ:CBST) has moved down from its 20 days moving average -5.75% and positively from its 50 days moving average 1.55%. Cubist Pharmaceuticals Stock Rating Reaffirmed by Zacks (CBST) The Utah People's Post - Jun 3, 2013 They currently have a $59.00 price target on the stock. Zacks' price objective suggests a potential upside of 7.18% from the company's current price. Zacks' analyst wrote, “Cubist Pharmaceutical's first quarter 2013 adjusted earnings of $0.34 per share ... Cubist Pharmaceuticals PT Raised to $65.00 at Wedbush (CBST) Daily Political - May 24, 2013 Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. Cubist Pharmaceuticals Downgraded by Janney Montgomery Scott to Neutral ... - Zolmax

 

DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX

iStockAnalyst (press release) Stock Upgrades And Downgrades: CBST, CCL, CMA, COH, OIS, SF, VFC, WCG iStockAnalyst (press release) Wells Fargo and William Blair downgraded the stock to "Market Perform" from "Outperform". Shares dropped 6.20 percent to trade at $33.12. Cubist Pharmaceuticals Inc. (NASDAQ: CBST) upgraded to "Hold" from "Sell" at Cantor. Shares rose 1.66 percent to ... and more » Cubist Pharmaceuticals Stock Rating Lowered by Janney Montgomery Scott ... Watch List News (press release) Cubist Pharmaceuticals logo Janney Montgomery Scott lowered shares of Cubist Pharmaceuticals (NASDAQ: CBST) from a buy rating to a neutral rating in a report released on Friday, TheFlyOnTheWall.com reports. Janney Montgomery Scott currently has ... Cubist Pharmaceuticals Stock Rating Reaffirmed by Zacks (CBST) The Utah People's Post Cubist Pharmaceuticals logo Cubist Pharmaceuticals (NASDAQ: CBST)'s stock had its “neutral” rating restated by Zacks in a report issued on Friday, AnalystRatingsNetwork.com reports. They currently have a $59.00 price target on the stock. Zacks' price ... Seven Most Active Stocks Watch List: Pinnacle Entertainment, Rexnord, Terex ... Equity Observer With a recent loss of -0.40%, to $49.97, the share price of Cubist Pharmaceuticals Inc (NASDAQ:CBST) has moved down from its 20 days moving average -5.75% and positively from its 50 days moving average 1.55%. About the Author: Chad covers U.S. and ... and more » Stock Analysts' Downgrades for May, 24th (BDEV, BT, BT.A, CBST, CNC, CRM ... Zolmax Barratt Developments (LON: BDEV) was downgraded by analysts at Liberum Capital from a buy rating to a hold rating. They currently have GBX 358 ($5.50) price target on the stock, up from their previous price target of GBX 270 ($4.15). BT Group plc (NYSE ... and more » Stock Analysts' Upgrades for May, 21st (AMT, BLK, BPTY, CBST, CNQ, CNW ... Zolmax Cubist Pharmaceuticals (NASDAQ: CBST) was upgraded by analysts at Cantor Fitzgerald from a sell rating to a hold rating. Cantor Fitzgerald currently has $49.00 price target on the stock, up from their previous price target of $40.00. Canadian Natrl Res ... and more » Stock Analysts' Price Target Changes for May, 21st (BA, CBST, CCL, CPB, ECL ... Zolmax Boeing (NYSE: BA) had its target price boosted by UBS AG from $75.00 to $100.00. UBS AG currently has a neutral rating on the stock. Cubist Pharmaceuticals (NASDAQ: CBST) had its price target boosted by RBC Capital from $53.00 to $63.00. Cubist Pharmaceuticals Stock Rating Upgraded by Cantor Fitzgerald (CBST) Mideast Time Cubist Pharmaceuticals logo Cubist Pharmaceuticals (NASDAQ: CBST) was upgraded by investment analysts at Cantor Fitzgerald from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday, AnalystRatings.Net reports. The firm currently ... US court ruling favors Cubist in patent case versus HospiraReuters Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to HoldStreetInsider.com (subscription) Cubist Pharmaceuticals shares leap late after ruling on patent casesMarketWatch (blog) RTT News -Benzinga -Techsonian (press release) all 11 news articles » MannKind Completes Afrezza Studies Zacks.com Other biopharma stocks, such as Jazz Pharmaceuticals Public Limited Company (JAZZ - Snapshot Report), Santarus, Inc. (SNTS - Snapshot Report) and Cubist Pharmaceuticals Inc. (CBST - Analyst Report), are comparatively well placed. While Jazz Pharma ... and more » Insider Monkey (blog) Here is What Hedge Funds Think About Cubist Pharmaceuticals Inc (CBST) Insider Monkey (blog) What have hedge funds been doing with Cubist Pharmaceuticals Inc (NASDAQ:CBST)? At Q1's end, a total of 22 of the hedge funds we track held long positions in this stock, a change of 16% from the previous quarter. With hedgies' positions undergoing ... and more »